Welcome to NewPressRelease.com a free press release service. Publishing press releases for Public Relations never been easier. Just register (it's free and it takes less then a 1 minute) then use Submit Press Release. Our services aim to help you reach journalists and to improve visibility in search engine listings, so you can get the most publicity possible.

GLOBAL MARKET RESEARCH | What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine T

Health and Fitness

(Free Press Release) Aarkstore announce a new report What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline through its vast collection of market research report.

GLOBAL MARKET RESEARCH | What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine T


Aarkstore.com announces, a new market research report is available in its vast collection:

What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline


The global market for human vaccines has experienced strong growth in the past few years, and R&D departments at many pharmaceutical companies are working on new prophylactics, some of which may see near-term marketing. What illnesses may see a vaccine option in the coming years? Which vaccines will have the most successful business model? Who are the major companies in this market, and possible new entrants? What can current vaccine success stories tell us about the future of the vaccine market? This report What's Next in Vaccines? examines and estimates the market for vaccines that have yet to be launched, including the following target areas:

* Addiction
* Allergy
* Alzheimer’s Disease
* Anthrax
* Asthma
* Campylobacter Infection
* Chlamydia
* Croup
* Dengue Fever
* Diabetes
* Ebola
* Epstein-Barr Virus
* Enterotoxigenic Escherichia coli
* Helicobacter Pylori
* Hepatitis
* Herpesvirus
* Hookworm
* Hypertension
* Leishmaniasis
* Malaria
* MRSA Infection
* Multiple Sclerosis
* Obesity
* Parainfluenza Virus Type 3
* Parkinson’s Disease
* Plague
* Respiratory Syncytial Virus
* Ross River Virus
* Shigellosis
* Smoking
* Stroke
* Tuberculosis
* West Nile Virus

Some of these vaccines may see success; some could be the blockbusters of the future. For marketers and industry watchers a knowledge of all of the potential vaccines will be important to understand how pharma is seeking to renew bottom line with aggressive prophylactic strategies, and who the winners and losers in the near future may be. Alison Sahoo has looked at the vaccine market three times in as many years for , and in this report applies a knowledge of what companies have done in the past to potential efforts.

There are a number of trends that will impact the industry that market watchers will want to know about, and has covered these trends; including: New Vaccine Technologies, DNA Vaccination, Innovative Delivery Systems, Edible Vaccines, Vaccine Patches, Funding Shortfalls. The report also discusses vaccine manufacturing methods and the approval process. In addition, the report focuses on the emerging vaccine activities of the following companies

* Acambis plc
* ACE BioSciences
* ALK-Abello A/S
* Allergy Therapeutics
* Bavarian Nordic A/S
* Baxter Healthcare
* Celldex Therapeutics
* Crucell
* Cytos Biotechnology Financial GlaxoSmithKline
* Hawaii Biotech
* Intercell
* Medimmune
* Merck & Co. Inc
* Mymetics
* Nabi Biopharmaceuticals
* Novartis
* Opexa Therapeutics
* Paladin Labs
* Sanofi Pasteur

This report provides forecasted revenues for products in development out to 2020. The report does not does not cover indication expansions of existing vaccine products, nor does it cover vaccines for which products currently exist and are widely available, but may need improvement. Development of vaccines that incorporate new production methods (such as the migration of chicken eggs to mammal, yeast or other cells) is also excluded. Cancer vaccines are excluded as has an entire report on this topic.

Sales estimates for each market segment represent global revenues and are expressed in current dollars. Information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources.

For More Related Reports Please follow the link :


GLOBAL MARKET RESEARCH | What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine T

Source: Press Release



If you have any questions regarding information in this press release, please contact the person listed as the Author or use the contact informations published in the press release. Please do not attempt to contact NewPressRelease.com. We are unable to assist you with any information regarding this release. NewPressRelease.com disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.

Related Items

All press release information on this site, including free press releases, is solely based on what our users submit. NewPressRelease.com disclaims that any right and responsibility for the information goes to the user who submit the press release. Some press release may be confusing without additional explanation. You should contact the provider with any questions about the information presented. In case some press release damages your benefits or violate your rights in any way, please contact us and we'll remove it immediately.

Copyright © 2008 - 2018 Free Press Release by NewPressRelease.com